Charlotte's Web Embraces New CMS Guidelines to Enhance Access to Premium Hemp Products

Charlotte's Web Holdings, Inc., recognized as a frontrunner in the botanical wellness space, is thrilled to announce its support for the recent guidelines issued by the Centers for Medicare & Medicaid Services (CMS). This development is a significant milestone that aims to improve patient access to eligible full-spectrum hemp products, marking a progressive step forward for the industry and consumers alike.

On March 20, 2026, Charlotte's Web conveyed their appreciation to CMS for its leadership in enhancing access through established frameworks under the CMS Innovation Center models. Key to this initiative is the newly established Substance Access Beneficiary Engagement Incentive (BEI), which has recognized specific hemp products as eligible under its guidelines. This includes those containing up to 3 mg per serving of tetrahydrocannabinols—a composition that ensures they remain non-intoxicating while offering the benefits of full-spectrum hemp-derived CBD.

CEO Bill Morachnick expressed gratitude towards CMS for adopting this thoughtful approach, paving the way for responsible, evidence-driven discussions regarding hemp products in clinical environments. He emphasized that the initiative aligns perfectly with Charlotte's Web's mission to provide safe, high-quality, and scientifically validated hemp options for consumers. The company remains dedicated to supporting legislative measures that prioritize patient safety and uphold the integrity of the hemp industry.

The framework established by CMS opens channels for healthcare providers and patients to engage in informed conversations about hemp products, fostering a science-driven policy environment that prioritizes consumer safety. By facilitating access to high-quality hemp options, CMS is recognizing the therapeutic potential of these products, which have garnered significant interest from both consumers and healthcare professionals alike.

Charlotte's Web prides itself on being a vertically integrated business that maintains stringent control over quality and consistency through analytical testing. Their diverse portfolio includes CBD oil tinctures, gummies aimed at sleep and exercise recovery, and even pet products. This meticulous attention to product quality not only reassures consumers but also reinforces its position as a trusted leader in the hemp extract wellness sector.

As Charlotte's Web continues to champion policy solutions that support transparency and availability of reliable full-spectrum hemp products, it reflects their commitment to holistic wellness through botanical innovations. The company will work closely with regulatory agencies to ensure that their products not only meet eligibility requirements but also contribute positively to the evolving landscape of hemp wellness.

By embracing these new guidelines, Charlotte's Web is not just enhancing their product offerings but also leading the conversation around responsible hemp consumption, potentially influencing future legislation that may further solidify the market for legal hemp products. This promising development is particularly important in light of the growing demand for hemp-based wellness solutions, which are increasingly sought after by health-conscious consumers.

In summary, the recent guidance from CMS is a watershed moment for the expanding hemp industry and Charlotte's Web is at the forefront, advocating for patient access and education regarding the safe use of these products in healthcare settings. As the landscape continues to evolve, Charlotte's Web remains committed to ensuring that high-quality hemp wellness options are accessible and safe for consumers everywhere.